These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11439320)

  • 21. The use of lipid-lowering agents in HIV-infected patients.
    Meienberg F; Battegay E; Bucher HC; Battegay M
    J HIV Ther; 2001 May; 6(2):40-4. PubMed ID: 11501203
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
    Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
    Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition.
    Losito A; Errico R; Santirosi P; Lupattelli T; Scalera GB; Lupattelli L
    Nephrol Dial Transplant; 2005 Aug; 20(8):1604-9. PubMed ID: 15870215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic statins: more data on newer lipid-lowering agents.
    Wierzbicki AS
    Curr Med Res Opin; 2001; 17(1):74-7. PubMed ID: 11464449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catheter-based therapy for atherosclerotic renal artery stenosis.
    White CJ
    Circulation; 2006 Mar; 113(11):1464-73. PubMed ID: 16549651
    [No Abstract]   [Full Text] [Related]  

  • 26. Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease.
    Pillay WR; Kan YM; Crinnion JN; Wolfe JH;
    Br J Surg; 2002 Jun; 89(6):737-40. PubMed ID: 12027983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease.
    Silva VS; Martin LC; Franco RJ; Carvalho FC; Bregagnollo EA; Castro JH; Gavras I; Gavras H
    Am J Hypertens; 2008 Oct; 21(10):1163-8. PubMed ID: 18670414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-lowering agents and their meaning in the treatment of the fat metabolism-atherosclerosis functional circle.
    Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):289-96. PubMed ID: 7263106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of statins in reversing atherosclerosis: what the latest regression studies show.
    Grines CL
    J Interv Cardiol; 2006 Feb; 19(1):3-9. PubMed ID: 16483333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anginin in the treatment of coronary artery disease].
    Markiewicz M; Korolko A; Jaroszyński G
    Pol Tyg Lek; 1973 Jun; 28(23):871-3. PubMed ID: 4720261
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ischemic renal disease: revascularization or conservative treatment?].
    Rodríguez Jornet A; Ibeas J; Ribera L; Real J; Perendreu J; Falcó J; Vallespín J; Allegué N; Giménez Gaibar A; García García M
    Nefrologia; 2005; 25(3):258-68. PubMed ID: 16053007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-atherosclerotic drugs].
    Berkhin EB
    Klin Med (Mosk); 1987 Feb; 65(2):14-20. PubMed ID: 3573697
    [No Abstract]   [Full Text] [Related]  

  • 33. [Statins: from hypocholesteremic drugs to antiatherogenic agents].
    Manzoli A; Patti G; D'Ambrosio A; Montesanti R; Calabrese V; Abbate A; Gioia G; Di Sciascio G
    Clin Ter; 2001; 152(5):307-13. PubMed ID: 11794851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
    Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
    Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging.
    Corti R; Osende JI; Fallon JT; Fuster V; Mizsei G; Jneid H; Wright SD; Chaplin WF; Badimon JJ
    J Am Coll Cardiol; 2004 Feb; 43(3):464-73. PubMed ID: 15013132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is renal artery stenting the correct treatment of renal artery stenosis? Case against angioplasty and stenting of atherosclerotic renal artery stenosis.
    Dworkin LD; Jamerson KA
    Circulation; 2007 Jan; 115(2):271-6; discussion 276. PubMed ID: 17228013
    [No Abstract]   [Full Text] [Related]  

  • 37. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets.
    Libby P; Aikawa M
    Nat Med; 2002 Nov; 8(11):1257-62. PubMed ID: 12411953
    [No Abstract]   [Full Text] [Related]  

  • 38. [The changing etiology and therapeutic situation of atherosclerotic renal artery stenosis].
    Wang F; Wang M; Liu YC; Wang HY
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2762-6. PubMed ID: 16324317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting.
    Powell BD; Bybee KA; Valeti U; Thomas RJ; Kopecky SL; Mullany CJ; Wright RS
    Am J Cardiol; 2007 Mar; 99(6):785-9. PubMed ID: 17350365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dyslipidemias and cardiovascular diseases: towards a new perspective].
    Darioli R; Depairon M; Perdrix J; Mooser V
    Rev Med Suisse Romande; 2002 Oct; 122(10):489-93. PubMed ID: 12494781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.